vs

Side-by-side financial comparison of AVADEL PHARMACEUTICALS PLC (AVDL) and MERCANTILE BANK CORP (MBWM). Click either name above to swap in a different company.

AVADEL PHARMACEUTICALS PLC is the larger business by last-quarter revenue ($77.5M vs $67.6M, roughly 1.1× MERCANTILE BANK CORP). MERCANTILE BANK CORP runs the higher net margin — 33.6% vs 0.0%, a 33.5% gap on every dollar of revenue. Over the past eight quarters, AVADEL PHARMACEUTICALS PLC's revenue compounded faster (99.6% CAGR vs 9.1%).

Avadel Pharmaceuticals, is an Irish specialty pharmaceutical company that focuses on sleep disorder medicines. Avadel markets products in the hospital and primary care spaces. The company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France.

Tamilnad Mercantile Bank Limited (TMB) is an Indian bank headquartered at Thoothukudi, Tamil Nadu. TMB was founded in 1921 as the Nadar Bank, but changed its name to Tamilnad Mercantile Bank in November 1962 to widen its appeal beyond the Nadar community. The bank currently has 600 full branches throughout India, 12 regional offices and two link offices, two central processing centres, one service branch, four currency chests, 48 eLobby centres, 262 cash recycler machines and 1151 automated ...

AVDL vs MBWM — Head-to-Head

Bigger by revenue
AVDL
AVDL
1.1× larger
AVDL
$77.5M
$67.6M
MBWM
Higher net margin
MBWM
MBWM
33.5% more per $
MBWM
33.6%
0.0%
AVDL
Faster 2-yr revenue CAGR
AVDL
AVDL
Annualised
AVDL
99.6%
9.1%
MBWM

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
AVDL
AVDL
MBWM
MBWM
Revenue
$77.5M
$67.6M
Net Profit
$20.0K
$22.7M
Gross Margin
Operating Margin
2.5%
Net Margin
0.0%
33.6%
Revenue YoY
54.9%
Net Profit YoY
100.8%
16.1%
EPS (diluted)
$0.00
$1.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVDL
AVDL
MBWM
MBWM
Q1 26
$67.6M
Q4 25
$62.1M
Q3 25
$77.5M
$62.4M
Q2 25
$68.1M
$60.9M
Q1 25
$52.5M
$57.3M
Q4 24
$50.4M
$58.5M
Q3 24
$50.0M
$58.0M
Q2 24
$41.5M
$56.8M
Net Profit
AVDL
AVDL
MBWM
MBWM
Q1 26
$22.7M
Q4 25
$22.8M
Q3 25
$20.0K
$23.8M
Q2 25
$9.7M
$22.6M
Q1 25
$-4.9M
$19.5M
Q4 24
$-5.0M
$19.6M
Q3 24
$-2.6M
$19.6M
Q2 24
$-13.8M
$18.8M
Gross Margin
AVDL
AVDL
MBWM
MBWM
Q1 26
Q4 25
Q3 25
Q2 25
90.7%
Q1 25
89.4%
Q4 24
90.5%
Q3 24
87.7%
Q2 24
93.3%
Operating Margin
AVDL
AVDL
MBWM
MBWM
Q1 26
Q4 25
42.0%
Q3 25
2.5%
44.0%
Q2 25
13.0%
42.6%
Q1 25
-5.7%
42.0%
Q4 24
-6.5%
39.7%
Q3 24
-0.7%
42.4%
Q2 24
-30.7%
41.4%
Net Margin
AVDL
AVDL
MBWM
MBWM
Q1 26
33.6%
Q4 25
36.8%
Q3 25
0.0%
38.1%
Q2 25
14.2%
37.1%
Q1 25
-9.4%
34.1%
Q4 24
-10.0%
33.5%
Q3 24
-5.2%
33.8%
Q2 24
-33.3%
33.1%
EPS (diluted)
AVDL
AVDL
MBWM
MBWM
Q1 26
$1.32
Q4 25
$1.41
Q3 25
$0.00
$1.46
Q2 25
$0.10
$1.39
Q1 25
$-0.05
$1.21
Q4 24
$-0.04
$1.20
Q3 24
$-0.03
$1.22
Q2 24
$-0.14
$1.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVDL
AVDL
MBWM
MBWM
Cash + ST InvestmentsLiquidity on hand
$91.6M
Total DebtLower is stronger
$1.5M
Stockholders' EquityBook value
$98.2M
$736.9M
Total Assets
$199.4M
$6.9B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVDL
AVDL
MBWM
MBWM
Q1 26
Q4 25
Q3 25
$91.6M
Q2 25
$81.5M
Q1 25
$66.5M
Q4 24
$73.8M
Q3 24
$65.8M
Q2 24
$71.4M
Total Debt
AVDL
AVDL
MBWM
MBWM
Q1 26
$1.5M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
AVDL
AVDL
MBWM
MBWM
Q1 26
$736.9M
Q4 25
$724.9M
Q3 25
$98.2M
$657.6M
Q2 25
$90.7M
$631.5M
Q1 25
$74.1M
$608.3M
Q4 24
$73.8M
$584.5M
Q3 24
$74.7M
$583.3M
Q2 24
$70.3M
$551.2M
Total Assets
AVDL
AVDL
MBWM
MBWM
Q1 26
$6.9B
Q4 25
$6.8B
Q3 25
$199.4M
$6.3B
Q2 25
$187.2M
$6.2B
Q1 25
$167.9M
$6.1B
Q4 24
$164.2M
$6.1B
Q3 24
$158.3M
$5.9B
Q2 24
$157.5M
$5.6B
Debt / Equity
AVDL
AVDL
MBWM
MBWM
Q1 26
0.00×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVDL
AVDL
MBWM
MBWM
Operating Cash FlowLast quarter
$22.2M
Free Cash FlowOCF − Capex
$22.2M
FCF MarginFCF / Revenue
28.7%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1110.25×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVDL
AVDL
MBWM
MBWM
Q1 26
Q4 25
$18.0M
Q3 25
$22.2M
$23.1M
Q2 25
$12.7M
$-7.8M
Q1 25
$-8.2M
$-3.0M
Q4 24
$7.9M
$101.1M
Q3 24
$-6.9M
$-8.1M
Q2 24
$-18.2M
$9.1M
Free Cash Flow
AVDL
AVDL
MBWM
MBWM
Q1 26
Q4 25
Q3 25
$22.2M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
FCF Margin
AVDL
AVDL
MBWM
MBWM
Q1 26
Q4 25
Q3 25
28.7%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Capex Intensity
AVDL
AVDL
MBWM
MBWM
Q1 26
Q4 25
Q3 25
0.0%
Q2 25
Q1 25
Q4 24
Q3 24
0.0%
Q2 24
Cash Conversion
AVDL
AVDL
MBWM
MBWM
Q1 26
Q4 25
0.79×
Q3 25
1110.25×
0.97×
Q2 25
1.31×
-0.35×
Q1 25
-0.15×
Q4 24
5.15×
Q3 24
-0.41×
Q2 24
0.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AVDL
AVDL

Segment breakdown not available.

MBWM
MBWM

Net Interest Income$55.9M83%
Noninterest Income$11.7M17%

Related Comparisons